Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Bio-Path Holdings (BPTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,168
  • Shares Outstanding, K 2,831
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,580 K
  • 60-Month Beta 3.34
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.30 +1.68%
on 05/24/19
19.00 -23.47%
on 05/15/19
-4.04 (-21.74%)
since 04/24/19
3-Month
1.84 +690.22%
on 02/27/19
73.52 -80.22%
on 03/07/19
+12.34 (+560.91%)
since 02/22/19
52-Week
1.61 +803.11%
on 01/22/19
73.52 -80.22%
on 03/07/19
-19.86 (-57.73%)
since 05/24/18

Most Recent Stories

More News
Bio-Path: 1Q Earnings Snapshot

BELLAIRE, Texas (AP) _ Bio-Path Holdings Inc. (BPTH) on Thursday reported a loss of $1.5 million in its first quarter.

BPTH : 14.54 (-0.82%)
Bio-Path Holdings Reports First Quarter 2019 Financial Results

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 14.54 (-0.82%)
Bio-Path Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 16, 2019 / Bio-Path Holdings, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 16, 2019 at 8:30 AM Eastern...

BPTH : 14.54 (-0.82%)
Bio-Path Holdings to Announce First Quarter 2019 Financial Results on May 16, 2019

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 14.54 (-0.82%)
Biotech Brief: FDA Fast Tracking Innovative Breakthrough Therapies For Cancer Patients

A recent headline from a report released by Friends of Cancer Research, made the following eye-opening statement: "ONE OF THE BIGGEST TREATMENT BREAKTHROUGHS IN THE PAST FIVE YEARS WASN'T A DRUG, BUT A...

WVE : 25.41 (+5.04%)
ZSAN : 2.73 (-1.09%)
BPTH : 14.54 (-0.82%)
PFE : 41.95 (+0.07%)
MBRX : 1.11 (-0.89%)
Biotech Brief: Clinical Progress Leading to New Technological Developments for Arrhythmia Monitoring

A recent market research report from a well-respected industry source, Grand View Research, said that it expects the Arrhythmia Monitoring Devices Market to be worth $8.41 billion by 2025 with a CAGR of...

ABT : 76.98 (+1.79%)
BSX : 38.47 (+1.80%)
JNJ : 138.85 (-0.67%)
BSGM : 6.87 (-4.32%)
BPTH : 14.54 (-0.82%)
Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 14.54 (-0.82%)
Medical Device Industry Revenues Should Outpace Healthcare Field

The U.S. markets are bullish on the future of the medical device markets. In addition to projections that postulate that: "In 2024, the total medical technology revenue globally is expected be nearly $600...

ALDX : 7.33 (+2.81%)
MHMNF : 54.5000 (unch)
ENDP : 5.95 (-2.78%)
ABBV : 80.06 (-1.34%)
BPTH : 14.54 (-0.82%)
SOLY : 5.73 (+4.95%)
Bio-Path Holdings Reports Full Year 2018 Financial Results

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 14.54 (-0.82%)
Bio-Path Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 20, 2019 / Bio-Path Holdings, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 20, 2019 at 8:30 AM Eastern...

BPTH : 14.54 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade BPTH with:

Business Summary

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout...

See More

Key Turning Points

2nd Resistance Point 15.13
1st Resistance Point 14.84
Last Price 14.54
1st Support Level 14.27
2nd Support Level 14.00

See More

52-Week High 73.52
Fibonacci 61.8% 46.05
Fibonacci 50% 37.56
Fibonacci 38.2% 29.08
Last Price 14.54
52-Week Low 1.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar